Catalyst Wire Dossier Catalyst Wire Dossier

HIV CN54gp140 vaccine

· Imperial College London
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HIV CN54gp140 vaccine, covering 2025-01-31 to 2025-01-31. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of HIV DNA-C CN54ENV and Recombinant HIV CN54gp140 Vaccines in Healthy Volunteers [Phase 1]

See pricing